Table 2:
Univariate analysis of factors associated with overall survival
| HR (95%CI) | p-value | |
|---|---|---|
| Extra-Adrenal Mets | 0.816 | |
| Yes | 0.95 (0.66-1.38 | |
| No | Reference | |
| Age | 0.782 | |
| >62 yr | 1.05 (0.73-1.51) | |
| <=62 yr | Reference | |
| Gender | 0.96 | |
| Male | 1.008 (0.69-1.46) | |
| Female | Reference | |
| Tumor size | <0.01 | |
| >4.5cm | 1.78 (1.22-2.58) | |
| <=4.5 cm | Reference | |
| Primary Site | ||
| NSCLC | 1.00 (0.67-1.49) | 0.973 |
| Renal | 0.42 (0.23-0.75) | <0.01 |
| Others | Reference | |
| Operation Approach | 0.19 | |
| Laparoscopic | 1.28 (0.87-1.88) | |
| Open | 49 (59%) | |
| Margin | <0.01 | |
| Positive | 2.1 (1.36-3.14) | |
| Negative | Reference | |
| Synchronous Disease | 0.825 | |
| No | 1.05 (0.70-1.53) | |
| Yes | Reference |